Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome

Hsin Ju Huang, Jieh-Neng Wang, Yu Chien Tsai, Chia Shiang Lin, Jing-Ming Wu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pulmonary embolism (PE) is a rare but life-threatening condition, which needs emergent treatment in children. Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients. We reported a 10-year-old girl who had diffused multiple pulmonary emboli due to primary antiphospholipid syndrome. The thrombi persisted in spite of intravenous heparin infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours.

Original languageEnglish
Pages (from-to)351-353
Number of pages3
JournalActa Paediatrica Taiwanica
Volume43
Issue number6
Publication statusPublished - 2002 Nov

Fingerprint

Antiphospholipid Syndrome
Thrombolytic Therapy
Pulmonary Embolism
Streptokinase
Embolism
Intravenous Infusions
Heparin
Thrombosis
Lung
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{255df917ad444b49a6349dede66acb98,
title = "Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome",
abstract = "Pulmonary embolism (PE) is a rare but life-threatening condition, which needs emergent treatment in children. Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients. We reported a 10-year-old girl who had diffused multiple pulmonary emboli due to primary antiphospholipid syndrome. The thrombi persisted in spite of intravenous heparin infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours.",
author = "Huang, {Hsin Ju} and Jieh-Neng Wang and Tsai, {Yu Chien} and Lin, {Chia Shiang} and Jing-Ming Wu",
year = "2002",
month = "11",
language = "English",
volume = "43",
pages = "351--353",
journal = "Pediatrics and Neonatology",
issn = "1875-9572",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "6",

}

Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome. / Huang, Hsin Ju; Wang, Jieh-Neng; Tsai, Yu Chien; Lin, Chia Shiang; Wu, Jing-Ming.

In: Acta Paediatrica Taiwanica, Vol. 43, No. 6, 11.2002, p. 351-353.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome

AU - Huang, Hsin Ju

AU - Wang, Jieh-Neng

AU - Tsai, Yu Chien

AU - Lin, Chia Shiang

AU - Wu, Jing-Ming

PY - 2002/11

Y1 - 2002/11

N2 - Pulmonary embolism (PE) is a rare but life-threatening condition, which needs emergent treatment in children. Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients. We reported a 10-year-old girl who had diffused multiple pulmonary emboli due to primary antiphospholipid syndrome. The thrombi persisted in spite of intravenous heparin infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours.

AB - Pulmonary embolism (PE) is a rare but life-threatening condition, which needs emergent treatment in children. Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients. We reported a 10-year-old girl who had diffused multiple pulmonary emboli due to primary antiphospholipid syndrome. The thrombi persisted in spite of intravenous heparin infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours.

UR - http://www.scopus.com/inward/record.url?scp=0036876890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036876890&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 351

EP - 353

JO - Pediatrics and Neonatology

JF - Pediatrics and Neonatology

SN - 1875-9572

IS - 6

ER -